4 States Tell FDA That REMS Restrictions Are Unneeded For Mifepristone
The attorneys general of California, Massachusetts, New Jersey and New York on June 5 submitted a citizen petition to the U.S. Food and Drug Administration urging the agency to remove the...To view the full article, register now.
Already a subscriber? Click here to view full article